BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Najar M, Melki R, Khalife F, Lagneaux L, Bouhtit F, Moussa Agha D, Fahmi H, Lewalle P, Fayyad-Kazan M, Merimi M. Therapeutic Mesenchymal Stem/Stromal Cells: Value, Challenges and Optimization. Front Cell Dev Biol 2021;9:716853. [PMID: 35096805 DOI: 10.3389/fcell.2021.716853] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Heris RM, Shirvaliloo M, Abbaspour-Aghdam S, Hazrati A, Shariati A, Youshanlouei HR, Niaragh FJ, Valizadeh H, Ahmadi M. The potential use of mesenchymal stem cells and their exosomes in Parkinson's disease treatment. Stem Cell Res Ther 2022;13:371. [PMID: 35902981 DOI: 10.1186/s13287-022-03050-4] [Reference Citation Analysis]
2 Merimi M, Rahmani S, Afailal Tribak A, Bouhtit F, Fahmi H, Najar M. Fundamental and Applied Advances in Stem Cell Therapeutic Research. Cells 2022;11:1976. [PMID: 35741105 DOI: 10.3390/cells11121976] [Reference Citation Analysis]
3 Ibáñez L, Guillem-llobat P, Marín M, Guillén MI. Connection between Mesenchymal Stem Cells Therapy and Osteoclasts in Osteoarthritis. IJMS 2022;23:4693. [DOI: 10.3390/ijms23094693] [Reference Citation Analysis]
4 Damerau A, Kirchner M, Pfeiffenberger M, Ehlers L, Do Nguyen DH, Mertins P, Bartek B, Maleitzke T, Palmowski Y, Hardt S, Winkler T, Buttgereit F, Gaber T. Metabolic reprogramming of synovial fibroblasts in osteoarthritis by inhibition of pathologically overexpressed pyruvate dehydrogenase kinases. Metabolic Engineering 2022. [DOI: 10.1016/j.ymben.2022.03.006] [Reference Citation Analysis]